Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 10/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 10/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 9/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.33 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.33 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | GRM5 | P41594 | 3/20 | 0.32 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7175488 | 1.00 | CHRNB2 (0.38) | CHRNB2CHRNA4CHRNA7PTPN1PTPN11 | |
| SCHEMBL7119650 | 0.85 | CHRNB2 (0.39) | CHRNB2CHRNA4CHRNA7PDE10A | |
| SCHEMBL7595144 | 0.84 | PTPN1 (0.49) | CHRNB2CHRNA4CHRNA7PTPN1PTPN11 | |
| SCHEMBL7117126 | 0.84 | PTPN1 (0.49) | CHRNB2CHRNA4CHRNA7PTPN1PTPN11 | |
| SCHEMBL7114589 | 0.84 | CHRNA7 (0.42) | CHRNB2CHRNA4CHRNA7USP30 | |
| SCHEMBL7582167 | 0.82 | PTPN1 (0.35) | CHRNB2CHRNA4CHRNA7PTPN1PTPN11 | |
| SCHEMBL7218204 | 0.82 | CHRNB2 (0.34) | CHRNB2CHRNA4CHRNA7 | |
| SCHEMBL7128777 | 0.82 | PTPN1 (0.35) | CHRNB2CHRNA4CHRNA7PTPN1PTPN11 | |
| SCHEMBL7225519 | 0.81 | PTPN1 (0.38) | CHRNB2CHRNA4CHRNA7PTPN1PTPN11 | |
| SCHEMBL7125448 | 0.81 | CHRNB2 (0.37) | CHRNB2CHRNA4CHRNA7PTPN1PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1311505-A2 | QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE ( NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS ) | PHARMACIA & UPJOHN COMPANY (US) | 2003-05-21 | — | — | EP | claimed |
| WO-2002016355-A2 | QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC) ACETYLCHOLINE RECEPTOR LIGANDS | PHARMACIA & UPJOHN COMPANY (US) | 2002-02-28 | — | — | WO | claimed |
| EP-1311505-A2 | QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE ( NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS ) | PHARMACIA & UPJOHN COMPANY (US) | 2003-05-21 | — | — | EP | disclosed |
| WO-2002016355-A2 | QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC) ACETYLCHOLINE RECEPTOR LIGANDS | PHARMACIA & UPJOHN COMPANY (US) | 2002-02-28 | — | — | WO | disclosed |